BIOIVT

Company Overview

BioIVT is a life science company that supplies biological materials, in vitro models, and specialty research services to pharmaceutical, biotechnology, and academic laboratories. It focuses on providing high-quality human and animal biospecimens, primary cells, and subcellular fractions that are used widely in drug discovery, preclinical research, and in vitro toxicology.

BioIVT’s portfolio supplies primary human hepatocytes, nonparenchymal liver cells, microsomes, S9 fractions, and transporter-qualified systems that researchers use to study drug metabolism, hepatotoxicity, transporter interactions, and other mechanistic pathways. Alongside these materials, it offers a range of in vitro ADME-Tox services, including cytotoxicity and metabolism assays, as well as tools for mitochondrial toxicity and reactive metabolite evaluation, helping teams identify safety issues early in the development process.

BioIVT provides access to clinically annotated donor material, disease-state tissues, and customized co-culture models, enabling more physiologically relevant toxicity studies. The resources allow researchers to evaluate metabolic liabilities, immune-mediated toxicity, and other safety endpoints using human-derived systems.

Company's Business Segments

• Biological Specimens : This segment includes Biofluids (Blood-derived), Biofluids (Other), Cell Products, Exosomes, Media / Reagents / Kits, Molecular Products, Subcellular Fractions & Recombinant Enzymes, Tissue, Customize Product
• Value-added Services : This segment of services includes In Vitro ADME Programs, Bioanalysis, In Vivo ADME & PK Studies, Biospecimen Characterization, ADME Consulting